Results Snapshot
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2024 is 36.88% vs -13.63% in Dec 2023
Consolidate Net Profit
YoY Growth in nine months ended Dec 2024 is 128.37% vs -57.12% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2024 is 64.89% vs -39.01% in Dec 2023
Interest
YoY Growth in nine months ended Dec 2024 is -30.60% vs 28.57% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2024 has improved from Dec 2023
Compare Nine Monthly Results Of Epigral With
Nine Monthly - Net Sales
YoY Growth in nine months ended Dec 2024 is 36.88% vs -13.63% in Dec 2023
Nine Monthly - Consolidate Net Profit
YoY Growth in nine months ended Dec 2024 is 128.37% vs -57.12% in Dec 2023
Nine Monthly - Operating Profit (PBDIT)
YoY Growth in nine months ended Dec 2024 is 64.89% vs -39.01% in Dec 2023
Nine Monthly - Interest
YoY Growth in nine months ended Dec 2024 is -30.60% vs 28.57% in Dec 2023
Nine Monthly - Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2024 has improved from Dec 2023